Levels of BDNF |
Reduced BDNF levels have been observed in individuals with major depressive disorder [45]. |
Changes in structure and function |
Deficiencies or imbalances in BDNF levels may contribute to the development of depression by promoting structural and functioning changes [7], such as reduced dendritic complexity [37]. |
Serotonin influence |
BDNF is influenced by serotonin, and serotonin activation can stimulate BDNF synthesis and release. Serotonin receptors can also modulate BDNF expression, influencing neuronal function and, consequently, mood regulation [59]. |
Neuroplasticity |
BDNF is involved in neuroplasticity, which is crucial for synaptic connections and structural changes in the brain related to depressive disorder [37]. |
Antidepressant effects |
Different antidepressants can enhance BDNF gene expression, contributing to their therapeutic effects [7]. |
Oxidative stress |
Oxidative stress can lower BDNF production and damage its signaling pathways. The connection between oxidative stress and BDNF levels plays a significant role in the development and progression of depression [11]. |
Hypothalamic–pituitary–adrenal (HPA) axis dysregulation |
Stress-induced HPA axis hyperactivity and the resulting increase in glucocorticoid levels diminish BDNF expression, playing an important role in the development of depression [10]. |